Connection

William Hrushesky to Circadian Rhythm

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Circadian Rhythm.
William Hrushesky
Connection Strength
6.888
Circadian Rhythm
  1. Measuring stem cell circadian rhythm. Methods Mol Biol. 2015; 1235:81-95.
    View in: PubMed
    Score: 0.447
  2. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011 May 23; 11:193.
    View in: PubMed
    Score: 0.348
  3. Circadian transcription profile of mouse breast cancer under light-dark and dark-dark conditions. Cancer Genomics Proteomics. 2010 Nov-Dec; 7(6):311-22.
    View in: PubMed
    Score: 0.335
  4. Clock genes and cancer. Integr Cancer Ther. 2009 Dec; 8(4):303-8.
    View in: PubMed
    Score: 0.314
  5. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009 Dec; 8(4):387-97.
    View in: PubMed
    Score: 0.314
  6. Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther. 2009 Dec; 8(4):309-16.
    View in: PubMed
    Score: 0.314
  7. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009 Oct; 26(7):1323-39.
    View in: PubMed
    Score: 0.311
  8. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem. 2009 Mar; 145(3):289-97.
    View in: PubMed
    Score: 0.295
  9. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009 Sep; 117(2):423-31.
    View in: PubMed
    Score: 0.286
  10. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006 Aug; 5(8):2023-33.
    View in: PubMed
    Score: 0.250
  11. Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer. 2005 Nov 28; 93(11):1202-8.
    View in: PubMed
    Score: 0.238
  12. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005 May; 91(1):47-60.
    View in: PubMed
    Score: 0.229
  13. Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst. 2004 Jun 02; 96(11):888-9.
    View in: PubMed
    Score: 0.215
  14. Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J Natl Cancer Inst. 1998 Oct 07; 90(19):1480-4.
    View in: PubMed
    Score: 0.145
  15. Circadian time structure of septic shock: timing is everything. J Infect Dis. 1997 May; 175(5):1283-4.
    View in: PubMed
    Score: 0.131
  16. Circadian rhythms and cancer chemotherapy. Crit Rev Eukaryot Gene Expr. 1996; 6(4):299-343.
    View in: PubMed
    Score: 0.120
  17. Larry Scheving and cancer chronotherapy. J Infus Chemother. 1995; 5(1):1-2.
    View in: PubMed
    Score: 0.112
  18. Cancer chronotherapy: is there a right time in the day to treat? J Infus Chemother. 1995; 5(1):38-43.
    View in: PubMed
    Score: 0.112
  19. Biological perspectives on circadian cancer therapy. J Infus Chemother. 1995; 5(4):182-90.
    View in: PubMed
    Score: 0.112
  20. Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med. 1994 Sep 01; 180(3):1059-65.
    View in: PubMed
    Score: 0.109
  21. Circadian pharmacodynamics of anticancer therapies. Clin Chem. 1993 Nov; 39(11 Pt 2):2413-8.
    View in: PubMed
    Score: 0.103
  22. Circadian cancer therapy. J Clin Oncol. 1993 Jul; 11(7):1403-17.
    View in: PubMed
    Score: 0.101
  23. Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
    View in: PubMed
    Score: 0.097
  24. The multifrequency (circadian, fertility cycle, and season) balance between host and cancer. Ann N Y Acad Sci. 1991; 618:228-56.
    View in: PubMed
    Score: 0.085
  25. Temporally optimizable delivery systems--sine qua non for molecular medicine. Preface. Ann N Y Acad Sci. 1991; 618:xi-xvii.
    View in: PubMed
    Score: 0.085
  26. More evidence for circadian rhythm effects in cancer chemotherapy: the fluoropyrimidine story. Cancer Cells. 1990 Mar; 2(3):65-8.
    View in: PubMed
    Score: 0.080
  27. Circadian-based infusional FUDR therapy. Oncol Nurs Forum. 1990 Jan-Feb; 17(1):49-56.
    View in: PubMed
    Score: 0.079
  28. Cancer chronotherapy: a drug delivery challenge. Prog Clin Biol Res. 1990; 341A:1-10.
    View in: PubMed
    Score: 0.079
  29. Oral temperature rhythmometry and substantial within-day variation in zidovudine levels following steady-state dosing in human immunodeficiency virus (HIV) infection. Prog Clin Biol Res. 1990; 341A:67-76.
    View in: PubMed
    Score: 0.079
  30. In this issue: circadian disruption and cancer. Integr Cancer Ther. 2009 Dec; 8(4):295-7.
    View in: PubMed
    Score: 0.079
  31. Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin. Invest New Drugs. 1988 Dec; 6(4):273-83.
    View in: PubMed
    Score: 0.073
  32. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008 Nov; 6(11):1786-93.
    View in: PubMed
    Score: 0.073
  33. Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma. Semin Surg Oncol. 1988; 4(2):110-5.
    View in: PubMed
    Score: 0.069
  34. Circadian susceptibility-resistance cycles to radiation and their manipulability by methylene blue. Pharmacol Ther. 1988; 39(1-3):397-402.
    View in: PubMed
    Score: 0.069
  35. Circadian pattern of continuous FUDR infusion reduces toxicities. Prog Clin Biol Res. 1987; 227B:357-73.
    View in: PubMed
    Score: 0.064
  36. Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
    View in: PubMed
    Score: 0.060
  37. Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006; 6(1):73-84.
    View in: PubMed
    Score: 0.060
  38. Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
    View in: PubMed
    Score: 0.057
  39. Circadian toxicology of cyclosporin. Toxicol Appl Pharmacol. 1985 Jan; 77(1):181-5.
    View in: PubMed
    Score: 0.056
  40. Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
    View in: PubMed
    Score: 0.052
  41. Circadian rhythmicity of polyamine urinary excretion. Cancer Res. 1983 Aug; 43(8):3944-7.
    View in: PubMed
    Score: 0.051
  42. Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
    View in: PubMed
    Score: 0.050
  43. Circadian time dependence of cisplatin urinary kinetics. Clin Pharmacol Ther. 1982 Sep; 32(3):330-9.
    View in: PubMed
    Score: 0.048
  44. Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 1982 Mar; 42(3):945-9.
    View in: PubMed
    Score: 0.046
  45. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol. 2001 May; 158(5):1793-801.
    View in: PubMed
    Score: 0.043
  46. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp Hematol. 1998 Jun; 26(6):523-33.
    View in: PubMed
    Score: 0.035
  47. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology. 1991 Aug; 101(2):410-5.
    View in: PubMed
    Score: 0.022
  48. Reprogramming SynchroMed pumps: unanticipated inaccuracy. J Clin Oncol. 1991 Jun; 9(6):1089-90.
    View in: PubMed
    Score: 0.022
  49. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. J Clin Oncol. 1990 Sep; 8(9):1504-13.
    View in: PubMed
    Score: 0.021
  50. Determination of the therapeutic index of floxuridine by its circadian infusion pattern. J Natl Cancer Inst. 1990 Mar 07; 82(5):386-93.
    View in: PubMed
    Score: 0.020
  51. Outpatient time-specified infusion of fluoropyrimidines by implanted pump is less costly than flat delivery by external pump. Prog Clin Biol Res. 1990; 341B:397-409.
    View in: PubMed
    Score: 0.020
  52. Circadian rhythm alteration in HIV infected subjects. Prog Clin Biol Res. 1990; 341A:437-49.
    View in: PubMed
    Score: 0.020
  53. Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
    View in: PubMed
    Score: 0.019
  54. Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Natl Cancer Inst. 1988 Oct 05; 80(15):1232-7.
    View in: PubMed
    Score: 0.018
  55. Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery. 1988 Aug; 104(2):398-403.
    View in: PubMed
    Score: 0.018
  56. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression. Pharmacotherapy. 1988; 8(1):47-51.
    View in: PubMed
    Score: 0.017
  57. Circadian characteristics of dialyzable and non-dialyzable human urinary electrolytes, trace elements and total solids. Chronobiol Int. 1988; 5(2):175-84.
    View in: PubMed
    Score: 0.017
  58. High-dose intensity systemic therapy of metastatic bladder cancer. J Clin Oncol. 1987 Mar; 5(3):450-5.
    View in: PubMed
    Score: 0.016
  59. [Biological rhythms and tumor markers in man. With special reference to the carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in digestive system tumors]. Acta Gastroenterol Belg. 1987 Jan-Feb; 50(1):12-21.
    View in: PubMed
    Score: 0.016
  60. Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humans. Anticancer Res. 1986 Sep-Oct; 6(5):1137-44.
    View in: PubMed
    Score: 0.016
  61. Cyclosporine timing and kidney damage. N Engl J Med. 1985 Jul 18; 313(3):184.
    View in: PubMed
    Score: 0.015
  62. Cisplatin neurotoxicity: failure to demonstrate vitamin B12 inactivation. Cancer Treat Rep. 1985 Apr; 69(4):453-5.
    View in: PubMed
    Score: 0.014
  63. 24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage. Am J Med. 1984 Sep; 77(3):399-406.
    View in: PubMed
    Score: 0.014
  64. Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat Rep. 1982 Nov; 66(11):1933-8.
    View in: PubMed
    Score: 0.012
  65. Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol. 1982 May; 18(5):471-7.
    View in: PubMed
    Score: 0.012
  66. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 1982 Mar; 42(3):950-5.
    View in: PubMed
    Score: 0.011
  67. Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer. 2000 Nov 01; 88(3):479-85.
    View in: PubMed
    Score: 0.010
  68. Time-varying effects in mice and rats of several synthetic ACTH preparations. Chronobiologia. 1980 Apr-Jun; 7(2):211-26.
    View in: PubMed
    Score: 0.010
  69. Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin. Chronobiologia. 1980 Apr-Jun; 7(2):227-44.
    View in: PubMed
    Score: 0.010
  70. A pharmacist's primer on chronotherapeutics. Am Pharm. 1992 Mar; NS32(3):77-83.
    View in: PubMed
    Score: 0.006
  71. The chronopharmacokinetics of cyclosporine and its metabolites in recipients of pancreas allografts. Transplant Proc. 1988 Apr; 20(2 Suppl 2):471-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.